NCT00414856View on ClinicalTrials.gov

Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux

PHASE1CompletedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

August 31, 2006

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG

AFQ056

Trial Locations (4)

Unknown

Novartis Investigative site, Brussels

Novartis Investigative site, Paris

Novartis Investigative Site, Nuremberg

Novartis Investigative site, Bern

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY